Yabao Pharmaceutical Group Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 694.3 million compared to CNY 793.21 million a year ago. Revenue was CNY 694.3 million compared to CNY 793.21 million a year ago. Net income was CNY 71.39 million compared to CNY 64.73 million a year ago. Basic earnings per share from continuing operations was CNY 0.0927 compared to CNY 0.0841 a year ago. Diluted earnings per share from continuing operations was CNY 0.0927 compared to CNY 0.0841 a year ago.